captopril has been researched along with Diabetic Glomerulosclerosis in 160 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (15.00) | 18.7374 |
| 1990's | 90 (56.25) | 18.2507 |
| 2000's | 30 (18.75) | 29.6817 |
| 2010's | 14 (8.75) | 24.3611 |
| 2020's | 2 (1.25) | 2.80 |
| Authors | Studies |
|---|---|
| Alizadeh-Fanalou, S; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Ghaffari, T; Moradi, N; Yarahmadi, S | 1 |
| Balochnejadmojarrad, T; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Kazemi Fard, T; Moradi, N | 1 |
| Jesson, MI; Nikolic-Paterson, DJ; Pullen, N; Schlerman, FJ; Tesch, GH | 1 |
| Chu, S; Li, H; Liu, D; Liu, X; Qu, X; Shuai, Y; Zhang, X; Zhao, H | 1 |
| An, W; Liu, Y; Niu, M; Shi, R; Wang, Y; Zhang, F | 1 |
| Helal, F; Lane, ME | 1 |
| Awad, AS; Cooper, TK; Gao, T; Morris, SM; You, H | 1 |
| Awad, AS; Cooper, TK; Gao, T; Gvritishvili, A; Tombran-Tink, J; You, H | 1 |
| Abd Allah, ES; Gomaa, AM | 1 |
| Davis, G; Harrison, JC; Sammut, IA; Walker, RJ; Yao, Y | 1 |
| Ku, SK; Lee, HS | 1 |
| Gao, YY; Ji, L; Lu, Q; Wang, JY; Wu, ZM; Yin, XX | 1 |
| Afshariani, R; Banihashemi, MA; Ghezlou, M; Moini, M; Roozbeh, J; Sagheb, MM; Salari, S | 1 |
| Felehgari, V; Khazaie, H; Malek-Khosravi, S; Mozafari, H; Rahimi, M; Rahimi, Z; Rezaei, M; Vaisi-Raygani, A; Yari, K | 1 |
| Gao, YY; Jiang, XL; Mou, J; Tang, DQ; Wei, YQ; Yang, DZ; Yin, XX | 1 |
| Fan, X; Harris, RC; Takahashi, T; Wang, S; Yang, H; Yang, S; Zhang, MZ | 1 |
| Bechtel, W; Bey, P; Bosukonda, D; Carlson, W; Kalluri, R; Kanasaki, K; Keck, P; LeBleu, VS; Okada, H; Rusckowski, M; Sugimoto, H; Taduri, G; Tampe, B; Tampe, D; Zeisberg, M | 1 |
| Akbar, DH; Amin, HA; Hagras, MM; Khorshid, OA | 1 |
| Bicket, DP | 1 |
| Fisher, ND; Gordon, MS; Hollenberg, NK; Laffel, LM; Lansang, MC; Perkins, B; Price, DA; Williams, GH | 1 |
| Emoto, M; Hosoi, M; Inaba, M; Ishimura, E; Kawagishi, T; Matsumoto, N; Nakatani, T; Nishizawa, Y; Shoji, S; Shoji, T; Taniwaki, H | 1 |
| Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K | 1 |
| Akalin, S; Akoğlu, E; Ersöz, O; Haklar, G; Küçükkaya, B; Yavuz, D | 1 |
| Krantz, MJ | 1 |
| Kanaki, T; Matsuda, M; Naitoh, T; Tsuruzoe, N; Yotsumoto, T | 1 |
| Ghini, B; Lehfeld, LS; Lopes de Faria, JB; Silveira, LA | 1 |
| Amini, M; Aminian, T; Aminorroaya, A; Gharavi, M; Janghorbani, M; Rezvanian, H | 1 |
| Leehey, DJ; Singh, AK; Singh, R | 1 |
| Godes, M; Hocher, B; Neumayer, HH; Richter, CM; Simon, K; Thöne-Reinke, C; Thormählen, D | 1 |
| Shlipak, M | 1 |
| Carrera, MJ; Micaló, T; Montanya, E; Pérez-Maraver, M; Sahun, M; Soler, J; Vinzia, C | 1 |
| Liu, J; Liu, YH; Yang, L | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Gao, YY; Lu, Q; Pan, YM; Wang, JY; Yin, XX | 1 |
| Kageyama, S | 1 |
| Akbari, A; Doucette, S; Fergusson, D; Knoll, G; McCormick, BB; Sydor, A | 1 |
| Arnoni, CP; Boim, MA; Casarini, DE; Cristovam, PC; de Andrade, MC; Pereira, LG; Schor, N | 1 |
| Aurell, M; Björck, S; Delin, K; Herlitz, H; Larsson, O | 1 |
| Gans, DJ; Laffel, LM; McGill, JB | 1 |
| Scheen, AJ | 1 |
| Bomanji, JB; Britton, KE; Datseris, IE; Nijran, KS; Nimmon, CC; Siraj, QH; Sonmezoglu, K | 1 |
| Hommel, E; Parving, HH; Rossing, P; Smidt, UM | 2 |
| Guo, HF; Xiong, NN; Yu, JY | 1 |
| Bain, RP; Cattran, D; Hebert, LA; Lewis, EJ; Rohde, RD; Tolchin, N; Verme, D; Whittier, FC | 1 |
| Banyai, M; Capek, M; Kautzky-Willer, A; Ludvik, B; Prager, R; Schnack, C | 1 |
| Hardy, KJ | 1 |
| Jensovský, J | 1 |
| Lewis, EJ | 2 |
| Campese, VM; Huang, TP; Liou, HH | 1 |
| Berden, JH; de Nobel, E; Elving, LD; van Lier, HJ; Wetzels, JF | 1 |
| Gerasimenko, OI; Kutyrina, IM; Rogov, VA; Sheremet'eva, OV; Shestakova, MV; Tareeva, IE; Zverev, KV | 1 |
| Yamaguchi, M | 1 |
| Berger, M; Mühlhauser, I; Sawicki, PT | 1 |
| Fournier, A; Lalau, JD | 1 |
| Parving, HH | 2 |
| Lopez, A; Marantz, PR | 1 |
| Bain, RP; Breyer, JA; Hunsicker, LG; Lewis, EJ | 1 |
| Raskovic, M; Ratzmann, KP; Schimke, E | 1 |
| Motala, AA; Omar, MA; Randeree, HA; Seedat, MA | 1 |
| Chase, HP; Garg, SK; Harris, S; Holmes, DL; Hoops, S; Jackson, WE | 1 |
| Alagözlü, H; Erdoğan, GH; Gültekin, F; Ozersoy, U | 1 |
| Groop, LC; Mogensen, CE; Pauls, JF; Viberti, G | 1 |
| Komers, R; Malý, J; Simková, R | 1 |
| Baak, MA; Delemarre-van de Waal, HA; Odink, RJ | 1 |
| Bindlish, V; Jaber, LA; Melchior, WR | 1 |
| Bain, RP; Hunsicker, LG; Lewis, EJ; Rohde, RD | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Abad, E; Johnston, S; Lucas, A; Reverter, JL; Romero, R; Salinas, I; Sanmarti, A | 1 |
| Materson, BJ | 1 |
| Cambien, F; Jacobsen, P; Lecerf, L; Parving, HH; Poirier, O; Rossing, P; Tarnow, L | 2 |
| Bar, J; Boner, G; Erman, A; Hod, M; Karp, M; Ovadia, J; Peled, Y; Rabinerson, D; van Dijk, DJ; Weintraub, N | 1 |
| Donnelly, R; Molyneaux, LM; Willey, KA; Yue, DK | 1 |
| Chang, CC; Chuang, LY; Guh, JY; Yang, ML; Yang, YL | 1 |
| Firth, LM; Lewis, EJ; Rodby, RA | 1 |
| Molyneaux, LM; Willey, KA; Yue, DK | 1 |
| Hannedouche, T; Le Pen, C; Lévy, P; Petitjean, P | 1 |
| Barkai, L; Soós, A; Vámosi, I | 1 |
| Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Fukunaga, Y; Inoue, D; Koshiyama, H; Maeda, S; Sakaguchi, H | 1 |
| Campbell, O; Guasch, A; Macon, E; Nzerue, C; Parham, M; Zayas, CF | 1 |
| Fukui, M; Shou, I; Tang, Z; Tomino, Y; Wang, LN | 1 |
| Bagust, A; Hendry, BM; Hummel, S; Piercy, J; Viberti, GC | 1 |
| Naitoh, T; Shikada, K; Tanaka, S; Yotsumoto, T | 1 |
| Beyer, KH; Follansbee, MH; Griffith, JW; Vesell, ES | 1 |
| Phillips, PJ; Popplewell, PY; Tallis, GA | 1 |
| Kitsukawa, R | 1 |
| Kumar, PD; Rajaratnam, K | 1 |
| Flyvbjerg, A; Grønbaek, H; Lancranjan, I; Orskov, H; Osterby, R; Vogel, I | 1 |
| Hricik, DE; Justice, AC; Rodby, RA; Weiss, MF | 1 |
| Cziráki, A; Hunyady, B; Jávor, T; Mezey, B; Mózsik, G; Nagy, S; Nemessányi, Z; Rinfel, J; Schmidt, E | 1 |
| Casani, A; Chiarelli, F; Morgese, G; Pinelli, L; Verrotti, A | 1 |
| Lewis, EJ; Rodby, RA | 1 |
| Barosi, M; Brunetti, M; Garattini, L; Salvioni, F | 1 |
| Hansen, HP; Hommel, E; Mathiesen, ER; Parving, HH; Smidt, UM | 1 |
| Bain, RP; Blumenthal, S; Cattran, D; Hebert, LA; Levey, AS; Lewis, EJ; Lewis, JB; Rohde, RD; Spitalewitz, S; Whittier, F; Wilmer, WA | 1 |
| Chen, D; Gao, Y; Geng, J; Lü, R; Ren, K; Wang, X; Wang, Y; Yu, X; Zhao, J | 1 |
| Ahiskali, R; Akalin, S; Budak, Y; Ekicioglu, G; Emerk, K; Ersöz, O; Kuçükkaya, B; Yavuz, DG | 1 |
| Yoshikawa, H | 1 |
| Torffvit, O | 1 |
| Katoh, M; Kurosawa, Y; Narita, H; Ohmachi, Y; Tanaka, N; Yoneda, H | 1 |
| Coca, A; Ruilope, LM | 1 |
| Descombes, E; Fellay, G | 1 |
| Hansen, HP; Hommel, E; Jensen, BR; Parving, HH | 1 |
| Fukui, M; Shou, I; Tomino, Y | 1 |
| Larger, E; Marre, M | 1 |
| Isogai, S; Katayama, S; Kikkawa, R; Matsuura, N; Ohashi, Y; Sasaki, N; Tajima, N; Uchigata, Y; Urakami, T | 1 |
| Studney, D | 1 |
| Cheung, BM | 1 |
| Ha, H; Kim, KH | 1 |
| Bain, R; Hunsicker, LG; Kobrin, S; Lewis, EJ; McGill, J; Rohde, R | 1 |
| Berden, JH; de Nobel, E; Elving, LD; Hoitsma, AJ; Wetzels, JF | 1 |
| Matsubara, M; Saito, T; Taguma, Y; Yoshinaga, K | 1 |
| Cho, C; Katz, A; Silverman, M; Whiteside, C | 1 |
| Fernandez Pardo, J; Fuente Jimenez, T; Garcia Alberola, A; Gonzalez-Sicilia de Llamas, L; Hernandez Cascales, J; Lafuente Lopez-Herrera, M | 1 |
| Hjelm, M | 1 |
| Giese, J; Hommel, E; Mathiesen, ER; Parving, HH | 1 |
| Agabiti-Rosei, E; Caldonazzo, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G | 1 |
| Hashimoto, T | 1 |
| Dedov, II; Lipitskaia, IIa; Mukhin, NA; Okunev, DIu; Pomerantseva, NV; Shestakova, MV; Titov, VN | 1 |
| Fujimi, S; Fujishima, M; Makita, Y; Onoyama, K; Washio, M | 1 |
| Felip, A; Lucas, A; Romero, R; Salinas, I; Sanmarti, A; Teixidó, J | 1 |
| Fong, M; Hart, LL | 1 |
| August, P; Lenz, T | 1 |
| Chan, MK; Cheng, IK; Ma, JT; Yeh, GR | 1 |
| Ansorge, G; Eisenhauer, T; Jungmann, E; Scherberich, J; Talartschik, J; Warneboldt, D | 1 |
| Grönhagen-Riska, C | 1 |
| Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G | 1 |
| Shachar, A; Shoenfeld, Y | 1 |
| Hommel, E; Larsen, M; Lund-Andersen, H; Parving, HH | 2 |
| Scapellato, L; Stornello, M; Valvo, EV | 1 |
| Agabiti-Rosei, E; Cimino, A; Giustina, A; Giustina, G; Muiesan, G; Romanelli, G; Valentini, U | 1 |
| Burr, AJ; Hay, J | 1 |
| Damkjaer Nielsen, M; Giese, J; Hommel, E; Parving, HH | 1 |
| Barrientos, A; Coronel, F; Cruceyra, A; Hortal, L; Naranjo, P | 1 |
| Anderson, S; Brenner, BM; Garcia, DL; Rennke, HG | 1 |
| Hommel, E; Mathiesen, ER; Parving, HH | 1 |
| Leone, S; Scapellato, L; Stornello, M; Valvo, EV; Vasques, E | 1 |
| Aurell, M; Björck, S; Granerus, G; Herlitz, H; Mulec, H; Nyberg, G | 1 |
| Antiga, L; Bedogna, V; Bommartini, F; Casagrande, P; Maschio, G; Oldrizzi, L; Rugiu, C; Valvo, E; Zamboni, M | 1 |
| Bringer, J; Insua, A; Mimran, A; Mirouze, J; Monnier, L; Ribstein, J | 1 |
| Insua, A; Mimran, A; Ribstein, J | 1 |
| Holländer, E | 2 |
| Damkjaer Nielsen, M; Edsberg, B; Giese, J; Hommel, E; Mathiesen, E; Parving, HH | 1 |
| Chimori, K; Kosaka, J; Miura, K; Miyazaki, S; Sakanaka, A; Yasuda, K | 1 |
| Hommel, E; Parving, HH; Smidt, UM | 1 |
| Gisinger, C; Hay, U; Ludvik, B; Schernthaner, G | 1 |
| Iida, N; Kitamura, E; Nakanishi, I; Okada, N; Thubakihara, Y; Yamato, E; Yokoyama, K | 1 |
| Caralps, A; Foz, M; Romero, R; Salinas, I; Sanmartí, A; Teixidó, J | 1 |
| Futaki, G; Ishizaki, M; Kitamoto, Y; Monma, H; Sasaki, Y; Sekino, H; Taguma, Y; Takahashi, H; Ueda, H | 1 |
19 review(s) available for captopril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Glucose; Captopril; Diabetic Nephropathies; Humans; Irbesartan; Losartan; Tetrazoles | 2004 |
[Clinical trials of ACE inhibitors and ARB for treatment of patients with hypertension, heart failure, and diabetic nephropathy in Japan--special reference to the dosage schedule and adverse effects].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Cough; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Japan; Losartan; Randomized Controlled Trials as Topic; Tetrazoles | 2008 |
The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Nephropathies; Humans; Kidney; Pentoxifylline; Phosphodiesterase Inhibitors; Proteinuria | 2008 |
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Capillary Resistance; Captopril; Diabetic Nephropathies; Dipeptides; Enalapril; Humans; Hyperglycemia; Lisinopril | 1993 |
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cross-Over Studies; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Humans; Hypertension; Indapamide | 1996 |
[Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach].
Topics: Adolescent; Adult; Captopril; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Costs; Humans; Middle Aged; Treatment Outcome | 1996 |
[The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
Topics: Adolescent; Albuminuria; Captopril; Child; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Treatment Outcome | 1996 |
Renal diseases in diabetes mellitus.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Calcium Channel Blockers; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Urinary Tract Infections | 1997 |
Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Risk Factors | 1998 |
Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dietary Proteins; Humans; Insulin | 1998 |
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors | 2000 |
Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertension; Kidney Glomerulus; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Blockade of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Humans; Hypertension; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Diabetic Nephropathies; Humans; Hypertension, Renal; Kidney Failure, Chronic | 1990 |
[ACE inhibitors' effect on kidney function].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Rats | 1990 |
[Captopril--new additional applications].
Topics: Animals; Captopril; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Lipids | 1990 |
48 trial(s) available for captopril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Diabetic Nephropathies; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria; Regression Analysis; Treatment Outcome | 2010 |
Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Male; Middle Aged; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 2003 |
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Heart Rate; Humans; Male; Middle Aged; Renal Circulation; Renin; Ultrasonography; Vascular Resistance | 2003 |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2003 |
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria | 2005 |
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2005 |
[Clinical observation on treatment of early diabetic nephropathy by milkvetch injection combined with captopril].
Topics: Adult; Aged; Albuminuria; Astragalus propinquus; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Injections; Male; Middle Aged; Phytotherapy | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1995 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; Captopril; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Least-Squares Analysis; Male; Middle Aged; Nifedipine; Prognosis; Prospective Studies; Regression Analysis | 1995 |
[Clinical observation on diabetic nephropathy treated with alcohol of Abelmoschus manihot].
Topics: Acetylglucosaminidase; Aged; Albuminuria; beta 2-Microglobulin; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Gliclazide; Humans; Lipid Peroxides; Male; Middle Aged; Proteinuria | 1995 |
Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.
Topics: Adolescent; Adult; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Time Factors | 1994 |
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.
Topics: Aged; Albuminuria; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Placebos | 1994 |
Therapeutic interventions in the progression of diabetic nephropathy.
Topics: Adrenergic beta-Antagonists; Adult; Captopril; Cost-Benefit Analysis; Creatinine; Diabetic Nephropathies; Diuretics; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Prospective Studies | 1994 |
Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydralazine; Kidney; Kidney Diseases; Male; Prospective Studies; Proteinuria; Renin | 1995 |
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Prospective Studies; Proteinuria; Treatment Outcome | 1994 |
Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cohort Studies; Creatinine; Diabetic Nephropathies; Double-Blind Method; Humans; Kidney; Kidney Transplantation; Middle Aged; Survival Analysis; Treatment Outcome | 1994 |
[The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Pressure; Captopril; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Kidney Tubules; Male; Middle Aged; Prospective Studies; Proteinuria; Time Factors | 1994 |
Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Male; Placebos; Prognosis | 1993 |
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
Topics: Adolescent; Adult; Albuminuria; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Proteinuria | 1994 |
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
Topics: Adult; Captopril; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Kidney; Male; Middle Aged; Patient Compliance; Prospective Studies | 1993 |
Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Captopril; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Diastole; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renal Circulation; Systole; Triglycerides | 1993 |
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Topics: Adolescent; Adult; Age of Onset; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Placebos; Proportional Hazards Models; Regression Analysis; Risk Assessment; Time Factors | 1996 |
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cross-Over Studies; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Humans; Hypertension; Indapamide | 1996 |
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cost-Benefit Analysis; Costs and Cost Analysis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Medicare; Time Factors; United States | 1996 |
Indapamide is as effective as captopril in the control of microalbuminuria in diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cross-Over Studies; Diabetic Nephropathies; Female; Humans; Indapamide; Male; Middle Aged | 1996 |
Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black People; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Isradipine; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Proteinuria | 1997 |
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Captopril; Creatinine; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lysine; Male; Neopterin; Predictive Value of Tests; Survival Analysis | 1998 |
Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Italy; Male | 1997 |
Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Humans; Kidney; Prospective Studies; Time Factors | 1999 |
A clinical trial of tang shen ning for treatment of diabetic nephropathy.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Qi; Yin Deficiency | 1998 |
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Prospective Studies; Reference Values; Time Factors | 2001 |
Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Imidazoles; Imidazolidines; Male; Placebos | 2002 |
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group.
Topics: Adolescent; Adult; Captopril; Clinical Protocols; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Prospective Studies | 1992 |
Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Blood Coagulation; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Esters; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Protease Inhibitors; Proteinuria; Uremia | 1992 |
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged | 1991 |
Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors | 1991 |
Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.
Topics: Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1990 |
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Topics: Administration, Oral; Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Exercise; Female; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine | 1990 |
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Topics: Adult; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Hemoglobin C; Humans; Male; Permeability; Prospective Studies | 1990 |
Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.
Topics: Adult; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Female; Heart Rate; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Nicardipine | 1989 |
Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Double-Blind Method; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Random Allocation; Time Factors | 1989 |
Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Ambulatory Care; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Prospective Studies; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Time Factors | 1989 |
Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Topics: Adolescent; Adult; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Humans; Kidney; Male; Middle Aged; Nifedipine | 1988 |
Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Nifedipine; Random Allocation | 1988 |
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged | 1986 |
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Male; Middle Aged | 1988 |
[Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
Topics: Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Hypertension, Renal; Male; Proteinuria | 1987 |
94 other study(ies) available for captopril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33.
Topics: Animals; ATP Binding Cassette Transporter 1; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; MicroRNAs; Rats; Rats, Wistar; Spironolactone | 2022 |
Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuretics; Drug Combinations; Drug Repositioning; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; MicroRNAs; Rats; Rats, Wistar; Spironolactone; Streptozocin; Transforming Growth Factor beta; Treatment Outcome | 2019 |
Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Azabicyclo Compounds; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Hypertension, Renal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Podocytes; Pyrimidines; Receptors, CCR2 | 2019 |
Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats.
Topics: Animals; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Wistar; RNA, Messenger; Streptozocin | 2020 |
Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cytoprotection; Diabetic Nephropathies; Gene Expression Regulation; Insulin; Kidney; Lipids; Male; Nebivolol; Nitric Oxide; Oxidative Stress; Rats; Rats, Zucker | 2018 |
Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginase; Boronic Acids; Captopril; Diabetic Nephropathies; Disease Progression; Kidney; Mice; Nitric Oxide Synthase Type III; Phosphorylation; Treatment Outcome | 2015 |
Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
Topics: Animals; Blood Pressure; Captopril; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Eye Proteins; Kidney; Macrophages; Male; Membrane Proteins; Mice; Nerve Growth Factors; Serpins | 2015 |
Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Curcumin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Kidney; Lipids; Male; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2015 |
Renal functional responses in diabetic nephropathy following chronic bilateral renal denervation.
Topics: Animals; Blood Pressure; Captopril; Denervation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Heart Rate; Kidney; Natriuretic Agents; Random Allocation; Rats, Transgenic; Renal Circulation; Renin-Angiotensin System; Sympathetic Nervous System | 2017 |
Effect of Picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hypoglycemic Agents; Kidney; Organ Size; Phytotherapy; Picrorhiza; Plant Extracts; Rats; Rats, Sprague-Dawley | 2008 |
Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
Topics: Animals; Basigin; Captopril; Cells, Cultured; Collagen Type IV; Connective Tissue Growth Factor; Diabetic Nephropathies; Extracellular Matrix; Ginkgo biloba; Glucose; Insulin-Like Growth Factor I; Laminin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesangial Cells; Plant Extracts; Plasminogen Activator Inhibitor 1; Rats; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2009 |
The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
Topics: Albuminuria; Alleles; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Factor V; Female; Genetic Predisposition to Disease; Humans; Iran; Losartan; Male; Middle Aged; Mutation; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome | 2011 |
Protective effects of rutin on rat glomerular mesangial cells cultured in high glucose conditions.
Topics: Animals; Antioxidants; Captopril; Cell Cycle; Cells, Cultured; Collagen Type IV; Culture Media; Diabetic Nephropathies; Glucose; Laminin; Mesangial Cells; Oxidative Stress; Protective Agents; Rats; Rutin; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1 | 2011 |
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hydralazine; Hydrochlorothiazide; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Renin-Angiotensin System; Reserpine | 2012 |
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Captopril; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Kidney; Kidney Tubules; Mice; Peptide Library; Peptides; Rats; Rats, Sprague-Dawley; Regeneration; Signal Transduction; Smad3 Protein; Structure-Activity Relationship; Transforming Growth Factor beta | 2012 |
Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Creatinine; Diabetic Nephropathies; Glyburide; Kidney; Male; Organ Size; Proteinuria; Rats | 2013 |
Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Kidney; Lipid Peroxidation; Losartan; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Wistar | 2003 |
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Evidence-Based Medicine; Humans; Hypertension; Losartan; Risk Management; Treatment Outcome | 2003 |
A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genes, Reporter; Hypoglycemic Agents; Kidney; Luciferases; Male; Mice; Organ Size; Plasmids; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone; Urodynamics | 2003 |
Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
Topics: Albuminuria; Amlodipine; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Fibronectins; Glomerular Filtration Rate; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Verapamil | 2004 |
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Glomerulus; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2005 |
Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Benzazepines; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-Converting Enzymes; Fibrosis; Kidney; Metalloendopeptidases; Neprilysin; Protease Inhibitors; Proteinuria; Rats; Rats, Wistar; Time Factors | 2004 |
Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood Glucose; Captopril; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ginkgo biloba; Kidney; Male; Matrix Metalloproteinase 2; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1 | 2007 |
ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.
Topics: Angiotensin II; Captopril; Cells, Cultured; Chymases; Diabetic Nephropathies; Glucose; Humans; Losartan; Mesangial Cells; Oligopeptides; Peptidyl-Dipeptidase A; RNA, Messenger | 2008 |
Renin secretion in advanced diabetic nephropathy.
Topics: Adult; Angiotensin II; Captopril; Chlorides; Diabetic Nephropathies; Dihydralazine; Humans; Hypertension; Middle Aged; Renin | 1984 |
[Pharmaclinics. Drug of the month. Captopril (Capoten) in diabetic nephropathies].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetic Nephropathies; Heart Failure; Humans; Hypertension, Renovascular | 1995 |
Predictive value of captopril transit renography in essential hypertension and diabetic nephropathy.
Topics: Adult; Aged; Captopril; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Radioisotope Renography; Renal Artery Obstruction; Technetium Tc 99m Mertiatide | 1995 |
Antihypertensives retarding progression of diabetic nephropathy.
Topics: Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans | 1995 |
[Use of captopril in diabetics].
Topics: Captopril; Diabetes Complications; Diabetic Nephropathies; Humans; Hypertension | 1995 |
Captopril and diabetic nephropathy.
Topics: Captopril; Diabetic Nephropathies; Humans | 1995 |
[The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Diabetic Nephropathies; Drug Evaluation; Enalapril; Female; Glomerulonephritis; Hemodynamics; Humans; Male; Middle Aged; Nephrotic Syndrome; Proteinuria | 1994 |
[A study on the pathogenesis of hyporeninemia in diabetics].
Topics: Adult; Aged; Blood Pressure; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Enzyme Precursors; Female; Humans; Hypoaldosteronism; Male; Middle Aged; Renin; Sodium, Dietary | 1994 |
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Topics: Adult; Albuminuria; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Humans; Male; Time Factors | 1994 |
Captopril, blood pressure, and diabetic nephropathy.
Topics: Blood Pressure; Captopril; Diabetic Nephropathies; Humans | 1994 |
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Topics: Captopril; Diabetic Nephropathies; Humans; Lipids | 1994 |
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Topics: Captopril; Creatinine; Diabetic Nephropathies; Glomerular Filtration Rate; Humans | 1994 |
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Topics: Black People; Captopril; Diabetic Nephropathies; Humans | 1994 |
Captopril for diabetic nephropathy.
Topics: Captopril; Clinical Trials as Topic; Diabetic Nephropathies; Humans | 1994 |
[Diabetic Nephropathy. Captopril can improve survival in hypertensive diabetics. Proceedings of a symposium at the IFECC III. Monte Carlo, January 1994].
Topics: Animals; Captopril; Diabetic Nephropathies; Humans | 1994 |
Effects of captopril and prazosin on renal function in diabetes.
Topics: Captopril; Diabetic Nephropathies; Double-Blind Method; Humans; Kidney; Kidney Function Tests; Prazosin | 1993 |
The effects of angiotensin-converting enzyme inhibitors on the clinical and biochemical parameters in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; Renal Plasma Flow; Time Factors | 1993 |
[Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
Topics: Adolescent; Adult; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Renal; Male; Middle Aged; Proteinuria; Renal Circulation | 1993 |
[Microalbuminuria as risk factor for nephropathy in children with insulin-dependent diabetes mellitus].
Topics: Adolescent; Age Factors; Albuminuria; Captopril; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Male; Nephelometry and Turbidimetry; Retrospective Studies; Risk Factors | 1993 |
Slowing the progression of diabetic nephropathy.
Topics: Captopril; Diabetic Nephropathies; Humans; Hypertension; Proteinuria | 1993 |
ACE inhibitors as a shield against diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Humans; Kidney Failure, Chronic | 1996 |
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Topics: Adult; Albuminuria; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Gene Deletion; Genotype; Glomerular Filtration Rate; Heterozygote; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome | 1996 |
Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Maternal Age; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Proteinuria; Retrospective Studies | 1995 |
Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Division; Cell Size; Diabetic Nephropathies; Down-Regulation; Gene Expression Regulation; Glucose; Kidney Tubules, Proximal; LLC-PK1 Cells; Receptors, Transforming Growth Factor beta; RNA, Messenger; Swine; Transforming Growth Factor beta | 1996 |
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 1997 |
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a patient with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Hypoglycemia; Middle Aged | 1997 |
Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Glucose; Captopril; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glutathione Peroxidase; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Superoxide Dismutase | 1997 |
Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; England; Health Care Costs; Humans; Kidney Failure, Chronic; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1997 |
Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertrophy; Imidazoles; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred Strains; Pyridines; Receptors, Angiotensin; Streptozocin | 1997 |
Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Guanidines; Hydrochlorothiazide; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Kidney; Kidney Function Tests; Male; Molecular Weight; Pyrazines; Rats; Rats, Sprague-Dawley; Serum Albumin; Streptozocin | 1997 |
The diabetic with renal impairment.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Coma; Diabetic Nephropathies; Humans; Hypertension; Male | 1997 |
[Management of diabetic nephropathy].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Captopril; Diabetic Nephropathies; Dietary Proteins; Humans; Peptidyl-Dipeptidase A; Polymorphism, Genetic | 1997 |
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Eating; Female; Insulin; Insulin-Like Growth Factor I; Kidney; Octreotide; Organ Size; Rats; Rats, Wistar; Streptozocin | 1998 |
[The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
Topics: Adult; Alleles; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chromosome Deletion; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prognosis | 1998 |
[Beneficial effect of the ACE inhibitor captopril in normotensive patients with insulin-dependent diabetes].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male | 1998 |
ACE inhibition in diabetic patients. Economic implications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Risk Factors | 1996 |
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies; Proteinuria; Randomized Controlled Trials as Topic; Remission Induction | 1999 |
The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Animals; Anions; Antihypertensive Agents; Captopril; Cell Membrane; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glycosaminoglycans; Losartan; Rats; Rats, Wistar; Sialic Acids; Streptozocin | 1999 |
[Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; RNA, Messenger; Thiazepines | 1999 |
Diabetic nephropathy: what causes to treat?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetic Nephropathies; Disease Progression; Humans; Hypertension; Kidney; Prognosis | 1999 |
Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Imidazolidines; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Renal Artery; Streptozocin | 2000 |
End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Captopril; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Tetrazoles | 2000 |
[Prediction, screening and treatment of renal complications of diabetes].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Primary Prevention; Prognosis; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Risk Factors; Time Factors | 2001 |
Amelioration of diabetic microalbuminuria and lipid peroxidation by captopril.
Topics: Albuminuria; Animals; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Insulin; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley | 1992 |
Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Circulation | 1992 |
Diabetic glomerulopathy following unilateral nephrectomy in the dog.
Topics: Albuminuria; Animals; Anions; Basement Membrane; Capillary Permeability; Captopril; Dextrans; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dogs; Glomerular Filtration Rate; Glomerular Mesangium; Hypertrophy; Indicator Dilution Techniques; Inulin; Kidney; Male; Microscopy, Electron; Nephrectomy; Organ Size; Pancreatectomy; Renin | 1990 |
Effects of captopril on diabetic nephropathy in hypertensive women.
Topics: Adult; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Humans; Hypertension; Middle Aged; Renin | 1991 |
Efficacy of captopril in postponing nephropathy.
Topics: Albuminuria; Captopril; Diabetic Nephropathies; Humans | 1991 |
ACE inhibition and diabetic nephropathy.
Topics: Albuminuria; Captopril; Diabetic Nephropathies; Humans | 1991 |
[Treatment of latent diabetic nephropathy with ACE inhibitor alacepril].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; beta 2-Microglobulin; Captopril; Creatinine; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Kidney; Male; Middle Aged | 1991 |
[The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
Topics: Adolescent; Adult; Albuminuria; Captopril; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Evaluation; Glomerular Filtration Rate; Humans; Kidney Function Tests; Middle Aged; Time Factors | 1991 |
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a diabetic hemodialysis patient.
Topics: Adult; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Humans; Hypertension; Hypoglycemia; Male; Nifedipine | 1991 |
Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria; Time Factors | 1990 |
Captopril in diabetic nephropathy.
Topics: Captopril; Diabetic Nephropathies; Humans | 1990 |
[Behavior of the renal functional reserve in type I diabetic patients: effect of ACE-inhibition].
Topics: Adult; Captopril; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged | 1990 |
Captopril and hypertension in black diabetics.
Topics: Black or African American; Captopril; Diabetic Nephropathies; Humans; Hypertension | 1989 |
Captopril, proteinuria and peritoneal protein leakage in diabetic patients.
Topics: Capillary Permeability; Captopril; Diabetic Nephropathies; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Proteins; Proteinuria | 1989 |
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Furosemide; Glomerular Filtration Rate; Humans; Male; Middle Aged | 1989 |
Short and long term effects of antihypertensive therapy in the diabetic rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Administration Schedule; Drug Therapy, Combination; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Male; Rats; Rats, Inbred SHR; Reserpine; Time Factors | 1989 |
Converting enzyme-inhibition in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Metoprolol; Prospective Studies | 1989 |
Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Kidney; Male; Middle Aged | 1989 |
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Kidney | 1986 |
Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.
Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria | 1988 |
Effect of antihypertensive (captopril) treatment on proteinuria in diabetic nephropathy.
Topics: Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Proteinuria | 1988 |
The hypotensive effect of single-dose captopril in diabetics.
Topics: Blood Pressure; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Drug Evaluation; Gabexate; Guanidines; Humans; Hypertension; Kallikreins; Renin | 1986 |
[Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Kidney Function Tests; Male; Middle Aged; Proteinuria; Time Factors | 1988 |
[Effect of combination therapy of low protein diet and captopril on proteinuria of diabetic nephropathy (DN)].
Topics: Adult; Aged; Captopril; Combined Modality Therapy; Diabetic Nephropathies; Dietary Proteins; Female; Humans; Male; Middle Aged; Proteinuria | 1988 |
[Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].
Topics: Adult; Aged; Captopril; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies | 1988 |
Effect of captopril on diabetic proteinuria.
Topics: Adult; Aged; Captopril; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Proteinuria | 1986 |
Effect of captopril on heavy proteinuria in azotemic diabetics.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Male; Middle Aged; Potassium; Proteinuria; Uremia | 1985 |